insights_auto
Why is UTHR up 12.55%?
Dive Deeperchevron_right
UTHR:NASDAQ
United Therapeutics Corp
$541.89
arrow_upward
+12.55%(+60.42) 1D
$542.00
arrow_upward
+0.02% (+0.11)bedtimeAfter hours
Closed: Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$482.20
High
$557.37
Low
$475.46
Mkt. cap
23.24B
Avg. vol.
644.73K
Volume
3.34M
P/E ratio
19.38
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
Open
$482.20
High
$557.37
Low
$475.46
Mkt. cap
23.24B
Avg. vol.
644.73K
Volume
3.34M
P/E ratio
19.38
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
21 minutes ago
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today
GuruFocus
·
2 hours ago
A Look at United Therapeutics Corp (UTHR) After 12.6% Gain -- GF Value $428.32 vs Price $541.89
Timothy Sykes
·
3 hours ago
United Therapeutics (UTHR) Rallies On Tyvaso Win And Massive Buyback
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com